Ambu AS (WBO:AMBU) Other Current Payables: €57.1 Mil (As of Mar. 2026)


WBO:AMBU Ambu AS WBO:AMBU
63 GF Score
Price €8.90
GF Value €17.17
Valuation Significantly Undervalued
View Full Analysis

What is Ambu AS Other Current Payables?

Ambu AS WBO:AMBU +0.28% 63 Other Current Payables is €57.1 Mil as of Mar. 2026. GuruFocus rates WBO:AMBU with a GF Score™ of 63/100 and a GF Value™ of €17.17 (Significantly Undervalued).

Ambu AS's Other Current Payables for the quarter that ended in Mar. 2026 was €57.1 Mil.

Ambu AS's quarterly Other Current Payables declined from Sep. 2025 (€60.0 Mil) to Dec. 2025 (€56.1 Mil) but then increased from Dec. 2025 (€56.1 Mil) to Mar. 2026 (€57.1 Mil).

Ambu AS's annual Other Current Payables declined from Sep. 2023 (€66.0 Mil) to Sep. 2024 (€58.9 Mil) but then increased from Sep. 2024 (€58.9 Mil) to Sep. 2025 (€60.0 Mil).


Ambu AS Other Current Payables Related Terms


Ambu AS Other Current Payables Historical Data

* Premium members only.

The historical data trend for Ambu AS's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ambu AS Other Current Payables Chart

Ambu AS Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 50.83 61.94 65.97 58.88 60.03

Ambu AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 50.68 52.28 60.03 56.10 57.13
WBO:AMBU
63GF Score
Ambu AS WBO:AMBU
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ambu AS Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of €57.1 Mil mean?
Ambu AS (WBO:AMBU) has a Other Current Payables of €57.1 Mil as of Mar. 2026. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Ambu AS and its competitors.
Is Ambu AS's Other Current Payables too high?
Ambu AS's current Other Current Payables is €57.1 Mil. Overall, Ambu AS has a GF Score™ of 63/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ambu AS's Other Current Payables compare to ABT and SYK?
Ambu AS's Other Current Payables of €57.1 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Medical Devices & Instruments company?
A good Other Current Payables depends on the Medical Devices & Instruments industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Ambu AS and its competitors. Ambu AS's current Other Current Payables is €57.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ambu AS stock overvalued right now?
Based on GuruFocus' analysis, Ambu AS (WBO:AMBU) is currently considered Significantly Undervalued. The stock's GF Value™ is €17.17, compared to a current price of €8.90 — trading 48.2% below its estimated fair value. The current Other Current Payables is €57.1 Mil. Ambu AS's overall GF Score™ is 63/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Ambu AS (WBO:AMBU), the current Other Current Payables is €57.1 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ambu AS (WBO:AMBU) Overvalued in 2026?

Based on GuruFocus' analysis, Ambu AS stock appears to be undervalued. The current stock price of €8.90 is trading 48.2% below its estimated GF Value™ of €17.17. GuruFocus considers Ambu AS to be Significantly Undervalued.

Key valuation signals for WBO:AMBU:

  • Other Current Payables: €57.1 Mil
  • GF Value™: €17.17 vs. price of €8.90 (48.2% below fair value)
  • GF Score™: 63/100

No single metric tells the full story. See the WBO:AMBU stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ambu AS Business Description

Address Baltorpbakken 13, Ballerup, DNK, DK-2750
Ambu AS provides medical technology solutions. The company's business consists of research and development of new solutions, which are then manufactured, marketed, and sold. It operates in two verticals: Endoscopy Solutions and Anesthesia & Patient Monitoring, with the majority of revenue being generated from the Endoscopy Solutions business. Geographical segments include North America, Europe, and the Rest of the World.
63GF Score

Get the complete analysis for WBO:AMBU

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.90
Price
€17.17
GF Value